Trial intelligence / Profile preview

TTAX01 for Complex Non-healing Diabetic Foot Ulcers

NCT03230175Phase 2Completed

Sponsor
BioTissue
Start
Oct 2017
Primary completion
Jan 2019
Modality
Tissue Cells
Countries
1
01

Overview

A Phase 2 trial of TTAX01 in diabetic foot ulcer (DFU), sponsored by BioTissue. Started Oct 2017; status: completed.

02

Drugs

TTAX01
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT03230175.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03230175.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call